ENTITY
CSL Ltd

CSL Ltd (CSL AU)

111
Analysis
Health CareAustralia
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
Refresh
30 Sep 2019 07:47

Developed Markets Opportunities

Continue to favor EAFE over EM. As long as the U.S. dollar remains elevated, we believe  developed international (EAFE) will remain in a leadership...

Logo
453 Views
Share
20 Sep 2019 11:25

The Deadcat Bounce in Aussie Value

The Global rotation away from Defensive stocks to cyclical Growth and Value over the past few weeks has not been impressive enough to convince us...

Logo
461 Views
Share
20 Sep 2019 03:06

China Biologic's Privatisation Redux

On Wednesday after market close, China Biologic Products (CBPO US) announced a surprising privatisation bid from a consortium for $120 per ADS. The...

Logo
492 Views
Share
16 Sep 2019 17:44

Ramsay Health Care A$1.3bn Placement - A Decent Stock but Past Performance Weighs

Ramsay Health Care's largest shareholder, Paul Ramsay Foundation, is selling AUD 1.3 billion block after market close today. In this insight, we...

Logo
465 Views
Share
09 Sep 2019 08:22

Global Equity Strategy: Guarded Optimism

Global equities (MSCI ACWI) are decisively breaking above 1-month resistance on US-China trade war optimism, incrementally improving the technical...

Logo
383 Views
Share
x